🔎 Trials Near Me

Home › Autoimmune Diseases

Autoimmune Diseases clinical trials recruiting in the U.S.

77 studies for Autoimmune Diseases are recruiting participants at sites across the United States.

Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.

Cities with the most studies

By state

Recently updated studies

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07103746

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

RecruitingPhase 2
Ages 4 to 69 · All sexes · Updated Nov 12, 2026 · NCT04339777

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

RecruitingObservational study
Up to age 99 · All sexes · Updated Nov 12, 2026 · NCT00001350

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT04751396

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

RecruitingObservational study
1 Month – 100 Years · All sexes · Updated Nov 12, 2026 · NCT00246857

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT00867269

Natural History of Bronchiectasis

RecruitingObservational studyHealthy volunteers welcome
Ages 5 to 100 · All sexes · Updated Nov 12, 2026 · NCT00943514

Secukinumab Open Label Roll-over Extension Protocol

RecruitingPhase 4
Ages 6 to 100 · All sexes · Updated Nov 9, 2026 · NCT04638647

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Nov 9, 2026 · NCT04097561

Study of PTC844 in Participants With Active Rheumatoid Arthritis

RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Nov 6, 2026 · NCT07779616

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

RecruitingPhase 2Healthy volunteers welcome
Ages 4 to 75 · All sexes · Updated Nov 5, 2026 · NCT02579967

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235

A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07902817

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06434363

NIAID Centralized Sequencing Protocol

RecruitingObservational studyHealthy volunteers welcome
1 Day – 100 Years · All sexes · Updated Nov 2, 2026 · NCT03206099

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Oct 30, 2026 · NCT07541287

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06948318

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Oct 26, 2026 · NCT00977977

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07885605

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.